Revolutionising Cancer Care

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) hosted at the University of Cambridge, with funding from The Mark Foundation for Cancer Research and the Cancer Research UK Cambridge Centre, aims to revolutionise cancer care by re-inventing the treatment pathway for patients.

Re-inventing the Patient Pathway

Research Areas

Breast Cancer

Read more Arrow

Ovarian Cancer

Read more Arrow

Pancreatic Cancer

Read more Arrow

Renal Cancer

Read more Arrow

Latest Updates

You can find a full list of media coverage about MFICM on the News page

Ask me anything about the use of artificial intelligence in healthcare

Ask me anything about the use of artificial intelligence in healthcare

Patient represetatives Ann, Frankie and Lorainne engage in a lively discussion with ICM researchers Professor James Brenton and Drs Ines Machado and Gabriel Funingana on the use of AI in healthcare, hosted by Ellie Wolmark.

Read More Arrow
Scientists create test to predict chemotherapy resistance in patients

Scientists create test to predict chemotherapy resistance in patients

The test uses changes to cancer DNA at diagnosis to predict which patients will be resistant to three common types of chemotherapy. This new method could benefit thousands of patients every year by helping them avoid treatments that are less likely to benefit them.

Read More Arrow
ICM Symposium – AI in Healthcare: Governance and Policy

ICM Symposium – AI in Healthcare: Governance and Policy

Downing College and online, Tuesday 8th July 2025

Read More Arrow

Key statistics

 
 
 
 
 
 
Statistics map
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect